Veganismusforum
Hier können Vorgehensweisen diskutiert und Informationen ausgetauscht werden, die dazu dienen, Veganismus zu fördern und eine vegane Gesellschaft zu etablieren.

 Forenübersicht  •  neues Thema  •  nach oben  •  zum Thema  •  Suche  •  Anmelden  •  RSS   voriger Beitrag  •  nächster Beitrag 
 Studien
Name: martin Permalink: https://tierrechtsforen.de/2/7313/7314

Datum: 10.10.09 10:14
Dieser Beitrag wurde 43425 mal gelesen

Die Studienübersichten stelle ich nicht rein, um Soja als besonders gesund darzustellen (auch wenn zutrifft, aber Gesundheit ist nunmal ein argumentatives Nono), sondern als weiterte Gegenargumente gegen die o.g. reichlich platte Anti-Soja-Propaganda.
Wieso die Gegenstudien (von denen es auch ein paar gibt) fehlerhaft sind, ist oben erläutert. Wer der Meinung ist, auch die Pro-Soja-Studien seien alle unwissenschaftlich usw., kann die Übersicht nutzen, um das zu beweisen.


Soja und Osteoporosevorbeugung

Vgl. http://www.isoflavon-forschung.de/en/clinical-effects/osteoporosis/117-osteoporosis.html




Soja und Brustkrebsvorbeugung

Erläuterungen und die zusammengefaßten Ergebnisse der einzelnen Studien als pdf unter: http://www.isoflavon-forschung.de/de/epidemiology/115-isoflavones-and-breast-cancer-epidemiology.html

Zitat:
Adebamowo, C. A., Hu, F. B., Cho, E., Spiegelman, D., Holmes, M. D., and Willett, W. C. (2005). Dietary patterns and the risk of breast cancer. Ann. Epidemiol. 15 (10): 789-795.

Antignac, J. P., Cariou, R., Le Bizec, B., Cravedi, J. P., and Andre, F. (2003). Identification of phytoestrogens in bovine milk using liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun. Mass Spectrom. 17 (12): 1256-1264.

Cotterchio, M., Boucher, B. A., Kreiger, N., Mills, C. A., and Thompson, L. U. (2008). Dietary phytoestrogen intake-lignans and isoflavones-and breast cancer risk (Canada). Cancer Causes Control 19 (3): 259-272.

Dai, Q., Franke, A. A., Jin, F., Shu, X. O., Hebert, J. R., Custer, L. J., Cheng, J., Gao, Y. T., and Zheng, W. (2002). Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol. Biomarkers Prev. 11 (9): 815-821.

Dai, Q., Franke, A. A., Yu, H., Shu, X. O., Jin, F., Hebert, J. R., Custer, L. J., Gao, Y. T., and Zheng, W. (2003). Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics. Cancer Epidemiol. Biomarkers Prev. 12 (6): 497-502.

Dai, Q., Shu, X. O., Jin, F., Potter, J. D., Kushi, L. H., Teas, J., Gao, Y. T., and Zheng, W. (2001). Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br. J. Cancer 85 (3): 372-378.

den Tonkelaar, I., Keinan-Boker, L., Veer, P. V., Arts, C. J., Adlercreutz, H., Thijssen, J. H., and Peeters, P. H. (2001). Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 10 (3): 223-228.

Do, M. H., Lee, S. S., Kim, J. Y., Jung, P. J., and Lee, M. H. (2007). Fruits, vegetables, soy foods and breast cancer in pre- and postmenopausal Korean women: a case-control study. Int. J. Vitam. Nutr. Res. 77 (2): 130-141.

dos Santos Silva, I, Mangtani, P., McCormack, V., Bhakta, D., McMichael, A. J., and Sevak, L. (2004). Phyto-oestrogen intake and breast cancer risk in South Asian women in England: findings from a population-based case-control study. Cancer Causes Control 15 (8): 805-818.

Fang, C. Y., Tseng, M., and Daly, M. B. (2005). Correlates of soy food consumption in women at increased risk for breast cancer. J. Am Diet. Assoc. 105 (10): 1552-1558.

Fink, B. N., Steck, S. E., Wolff, M. S., Britton, J. A., Kabat, G. C., Gaudet, M. M., Abrahamson, P. E., Bell, P., Schroeder, J. C., Teitelbaum, S. L., Neugut, A. I., and Gammon, M. D. (2007). Dietary Flavonoid Intake and Breast Cancer Survival among Women on Long Island. Cancer Epidemiol. Biomarkers Prev. 16 (11): 2285-2292.

Gikas, P. D. and Mokbel, K. (2005). Phytoestrogens and the risk of breast cancer: a review of the literature. Int. J. Fertil. Womens Med 50 (6): 250-258.

Grace, P. B., Taylor, J. I., Low, Y. L., Luben, R. N., Mulligan, A. A., Botting, N. P., Dowsett, M., Welch, A. A., Khaw, K. T., Wareham, N. J., Day, N. E., and Bingham, S. A. (2004). Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. Cancer Epidemiol. Biomarkers Prev. 13 (5): 698-708.

Hedelin, M., Lof, M., Olsson, M., Adlercreutz, H., Sandin, S., and Weiderpass, E. (2008). Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women. J. Nutr. 138 (5): 938-945.

Hirose, K., Imaeda, N., Tokudome, Y., Goto, C., Wakai, K., Matsuo, K., Ito, H., Toyama, T., Iwata, H., Tokudome, S., and Tajima, K. (2005). Soybean products and reduction of breast cancer risk: a case-control study in Japan. Br. J. Cancer 93 (1): 15-22.

Hirose, K., Tajima, K., Hamajima, N., Inoue, M., Takezaki, T., Kuroishi, T., Yoshida, M., and Tokudome, S. (1995). A large-scale, hospital-based case-control study of risk factors of breast cancer according to menopausal status. Jpn J. Cancer Res. 86 (2): 146-154.

Hirose, K., Takezaki, T., Hamajima, N., Miura, S., and Tajima, K. (2003). Dietary factors protective against breast cancer in Japanese premenopausal and postmenopausal women. Int. J. Cancer 107 (2): 276-282.

Horn-Ross, P. L., Hoggatt, K. J., West, D. W., Krone, M. R., Stewart, S. L., Anton, H., Bernstei, C. L., Deapen, D., Peel, D., Pinder, R., Reynolds, P., Ross, R. K., Wright, W., and Ziogas, A. (2002). Recent diet and breast cancer risk: the California Teachers Study (USA). Cancer Causes Control 13 (5): 407-415.

Horn-Ross, P. L., John, E. M., Lee, M., Stewart, S. L., Koo, J., Sakoda, L. C., Shiau, A. C., Goldstein, J., Davis, P., and Perez-Stable, E. J. (2001). Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am J. Epidemiol. 154 (5): 434-441.

Ingram, D., Sanders, K., Kolybaba, M., and Lopez, D. (1997). Case-control study of phyto-oestrogens and breast cancer. Lancet 350 (9083): 990-994.

Iwasaki, M., Inoue, M., Otani, T., Sasazuki, S., Kurahashi, N., Miura, T., Yamamoto, S., and Tsugane, S. (2008). Plasma Isoflavone Level and Subsequent Risk of Breast Cancer Among Japanese Women: A Nested Case-Control Study From the Japan Public Health Center-Based Prospective Study Group. J. Clin Oncol. 26 (10): 1677-1683.

Keinan-Boker, L., Der Schouw, Y. T., Grobbee, D. E., and Peeters, P. H. (2004). Dietary phytoestrogens and breast cancer risk. Am J. Clin Nutr. 79 (2): 282-288.

Key, T. J., Sharp, G. B., Appleby, P. N., Beral, V., Goodman, M. T., Soda, M., and Mabuchi, K. (1999). Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br. J. Cancer 81 (7): 1248-1256.

King, R. A., Mano, M. M., and Head, R. J. (1998). Assessment of isoflavonoid concentrations in Australian bovine milk samples. J. Dairy Res. 65 (3): 479-489.

Kuhl, H. (2008). Die Rolle der Gestagene ist nach wie vor ungeklärt. Dtsch. Apoth. Ztg. 148 (30): 3284-3286.

Lampe, J. W., Nishino, Y., Ray, R. M., Wu, C., Li, W., Lin, M. G., Gao, D. L., Hu, Y., Shannon, J., Stalsberg, H., Porter, P. L., Frankenfeld, C. L., Wahala, K., and Thomas, D. B. (2007). Plasma isoflavones and fibrocystic breast conditions and breast cancer among women in Shanghai, China. Cancer Epidemiol. Biomarkers Prev. 16 (12): 2579-2586.

Lee, H. P., Gourley, L., Duffy, S. W., Esteve, J., Lee, J., and Day, N. E. (1991). Dietary effects on breast-cancer risk in Singapore. Lancet 337 (8751): 1197-1200.

Lee, H. P., Gourley, L., Duffy, S. W., Esteve, J., Lee, J., and Day, N. E. (1992). Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore. Cancer Causes Control 3 (4): 313-322.

Lee, M. M., Chang, I. Y., Horng, C. F., Chang, J. S., Cheng, S. H., and Huang, A. (2005). Breast cancer and dietary factors in Taiwanese women. Cancer Causes Control 16 (8): 929-937.

Li, W., Ray, R. M., Lampe, J. W., Lin, M. G., Gao, D. L., Wu, C., Nelson, Z. C., Fitzgibbons, E. D., Horner, N., Hu, Y. W., Shannon, J., Satia, J. A., Patterson, R. E., Stalsberg, H., and Thomas, D. B. (2005). Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: a nested case-control study in Shanghai, China. Int. J. Cancer 115 (6): 981-993.

Linseisen, J., Piller, R., Hermann, S., and Chang-Claude, J. (2004). Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study. Int. J. Cancer 110 (2): 284-290.

Murkies, A., Dalais, F. S., Briganti, E. M., Burger, H. G., Healy, D. L., Wahlqvist, M. L., and Davis, S. R. (2000). Phytoestrogens and breast cancer in postmenopausal women: a case control study. Menopause 7 (5): 289-296.

Nagata, C. (2000). Ecological study of the association between soy product intake and mortality from cancer and heart disease in Japan. Int. J. Epidemiol. 29 (5): 832-836.

Nishio, K., Niwa, Y., Toyoshima, H., Tamakoshi, K., Kondo, T., Yatsuya, H., Yamamoto, A., Suzuki, S., Tokudome, S., Lin, Y., Wakai, K., Hamajima, N., and Tamakoshi, A. (2007). Consumption of soy foods and the risk of breast cancer: findings from the Japan Collaborative Cohort (JACC) Study. Cancer Causes Control 18 (8): 801-808.

Peterson, J., Lagiou, P., Samoli, E., Lagiou, A., Katsouyanni, K., La Vecchia, C., Dwyer, J., and Trichopoulos, D. (2003). Flavonoid intake and breast cancer risk: a case--control study in Greece. Br. J. Cancer 89 (7): 1255-1259.

Piller, R., Chang-Claude, J., and Linseisen, J. (2006). Plasma enterolactone and genistein and the risk of premenopausal breast cancer. Eur. J. Cancer Prev. 15 (3): 225-232.

Qin, L. Q., Xu, J. Y., Wang, P. Y., and Hoshi, K. (2006). Soyfood intake in the prevention of breast cancer risk in women: a meta-analysis of observational epidemiological studies. J. Nutr. Sci. Vitaminol. (Tokyo) 52 (6): 428-436.

Sanderson, M., Shu, X. O., Yu, H., Dai, Q., Malin, A. S., Gao, Y. T., and Zheng, W. (2004). Insulin-like growth factor-I, soy protein intake, and breast cancer risk. Nutr. Cancer 50 (1): 8-15.

Shannon, J., Ray, R., Wu, C., Nelson, Z., Gao, D. L., Li, W., Hu, W., Lampe, J., Horner, N., Satia, J., Patterson, R., Fitzgibbons, D., Porter, P., and Thomas, D. (2005). Food and botanical groupings and risk of breast cancer: a case-control study in Shanghai, China. Cancer Epidemiol. Biomarkers Prev. 14 (1): 81-90.

Shu, X. O., Jin, F., Dai, Q., Wen, W., Potter, J. D., Kushi, L. H., Ruan, Z., Gao, Y. T., and Zheng, W. (2001). Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol. Biomarkers Prev. 10 (5): 483-488.

Tempfer, C. B., Bentz, E. K., Leodolter, S., Tscherne, G., Reuss, F., Cross, H. S., and Huber, J. C. (2007). Phytoestrogens in clinical practice: a review of the literature. Fertil. Steril. 87 (6): 1243-1249.

Trock, B. J., Hilakivi-Clarke, L., and Clarke, R. (2006). Meta-analysis of soy intake and breast cancer risk. J. Natl. Cancer Inst. 98 (7): 459-471.

Tseng, M., Olufade, T., Kurzer, M. S., Wahala, K., Fang, C. Y., van der Schouw, Y. T., and Daly, M. B. (2008). Food frequency questionnaires and overnight urines are valid indicators of daidzein and genistein intake in U.S. women relative to multiple 24-h urine samples. Nutr. Cancer 60 (5): 619-626.

Verheus, M., van Gils, C. H., Keinan-Boker, L., Grace, P. B., Bingham, S. A., and Peeters, P. H. (2007). Plasma phytoestrogens and subsequent breast cancer risk. J. Clin Oncol. 25 (6): 648-655.

Ward, H. A., Chapelais, G., Kuhnle, G. G. C., Luben, R., Khaw, K.-T., and Bingham, S. (2008). Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the EPIC-Norfolk study. Breast Cancer Res. 10(2): R32

Witte, J. S., Ursin, G., Siemiatycki, J., Thompson, W. D., Paganini-Hill, A., and Haile, R. W. (1997). Diet and premenopausal bilateral breast cancer: a case-control study. Breast Cancer Res. Treat. 42 (3): 243-251.

Wu, A. H., Wan, P., Hankin, J., Tseng, C. C., Yu, M. C., and Pike, M. C. (2002). Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23 (9): 1491-1496.

Wu, A. H., Yu, M. C., Tseng, C. C., Hankin, J., and Pike, M. C. (2003). Green tea and risk of breast cancer in Asian Americans. Int. J. Cancer 106 (4): 574-579.

Wu, A. H., Yu, M. C., Tseng, C. C., and Pike, M. C. (2008). Epidemiology of soy exposures and breast cancer risk. Br. J. Cancer 98 (1): 9-14.

Wu, A. H., Ziegler, R. G., Horn-Ross, P. L., Nomura, A. M., West, D. W., Kolonel, L. N., Rosenthal, J. F., Hoover, R. N., and Pike, M. C. (1996). Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol. Biomarkers Prev. 5 (11): 901-906.

Yamamoto, S., Sobue, T., Kobayashi, M., Sasaki, S., and Tsugane, S. (2003). Soy, isoflavones, and breast cancer risk in Japan. J. Natl. Cancer Inst. 95 (12): 906-913.

Yuan, J. M., Wang, Q. S., Ross, R. K., Henderson, B. E., and Yu, M. C. (1995). Diet and breast cancer in Shanghai and Tianjin, China. Br. J. Cancer 71 (6): 1353-1358.

Zheng, W., Dai, Q., Custer, L. J., Shu, X. O., Wen, W. Q., Jin, F., and Franke, A. A. (1999). Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 8 (1): 35-40.




Soja und Gebärmutterkrebs

Erläuterungen und die zusammengefaßten Ergebnisse der einzelnen Studien als pdf unter: http://www.isoflavon-forschung.de/de/epidemiology/114-epidemiology-endometrial-cancer.html

Zitat:
Bandera, E. V., Williams, M. G., Sima, C., Bayuga, S., Pulick, K., Wilcox, H., Soslow, R., Zauber, A. G., and Olson, S. H. (2009). Phytoestrogen consumption and endometrial cancer risk: a population-based case-control study in New Jersey. Cancer Causes Control 20 (7): 1117-1127.

Dai, Q., Shu, X. O., Jin, F., Potter, J. D., Kushi, L. H., Teas, J., Gao, Y. T., and Zheng, W. (2001). Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br. J. Cancer 85 (3): 372-378.

A correlation between an increased intake of isoflavones and protection from endometrial cancer was observed in case control studies in at least three studies with a total of 3.490 patients and controls (Goodman et al. 1997; Horn-Ross et al. 2003; Xu et al. 2004). In contrast, the same effect was not found for the regular consumption of tofu in 1,623 patients and controls (Littman et al. 2001). The opposite question, i.e. the search for a potentially increased risk with tofu-rich diet, was answered in favour of soy in a large study with 26,896 participants: an increased risk of endometrial carcinoma was not observed (Hirose et al. 1996).]Goodman, M. T., Wilkens, L. R., Hankin, J. H., Lyu, L. C., Wu, A. H., and Kolonel, L. N. (1997). Association of soy and fiber consumption with the risk of endometrial cancer. Am J. Epidemiol. 146 (4): 294-306.

Hirose, K., Tajima, K., Hamajima, N., Takezaki, T., Inoue, M., Kuroishi, T., Kuzuya, K., Nakamura, S., and Tokudome, S. (1996). Subsite (cervix/endometrium)-specific risk and protective factors in uterus cancer. Jpn J. Cancer Res. 87 (9): 1001-1009.

Horn-Ross, P. L., John, E. M., Canchola, A. J., Stewart, S. L., and Lee, M. M. (2003). Phytoestrogen intake and endometrial cancer risk. J. Natl. Cancer Inst. 95 (15): 1158-1164.

Littman, A. J., Beresford, S. A., and White, E. (2001). The association of dietary fat and plant foods with endometrial cancer (United States). Cancer Causes Control 12 (8): 691-702.

Xu, W. H., Zheng, W., Xiang, Y. B., Ruan, Z. X., Cheng, J. R., Dai, Q., Gao, Y. T., and Shu, X. O. (2004). Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study. BMJ 328 (7451): 1285



Soja und Prostatakrebs

Vgl.: http://www.isoflavon-forschung.de/de/epidemiology/113-epidemiology-prostate-cancer.html

Zitat:
Akaza, H., Miyanaga, N., Takashima, N., Naito, S., Hirao, Y., Tsukamoto, T., and Mori, M. (2002). Is daidzein non-metabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration. Jpn J. Clin Oncol. 32 (8): 296-300.

Allen, N. E., Sauvaget, C., Roddam, A. W., Appleby, P., Nagano, J., Suzuki, G., Key, T. J., and Koyama, K. (2004). A prospective study of diet and prostate cancer in Japanese men. Cancer Causes Control 15 (9): 911-920.

Heald, C. L., Ritchie, M. R., Bolton-Smith, C., Morton, M. S., and Alexander, F. E. (2007). Phyto-oestrogens and risk of prostate cancer in Scottish men. Br. J. Nutr. 98 (2): 388-396.

Hebert, J. R., Hurley, T. G., Olendzki, B. C., Teas, J., Ma, Y., and Hampl, J. S. (1998). Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J. Natl. Cancer Inst. 90 (21): 1637-1647.

Hedelin, M., Klint, A., Chang, E. T., Bellocco, R., Johansson, J. E., Andersson, S. O., Heinonen, S. M., Adlercreutz, H., Adami, H. O., Gronberg, H., and Balter, K. A. (2006). Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden). Cancer Causes Control 17 (2): 169-180.

Jacobsen, B. K., Knutsen, S. F., and Fraser, G. E. (1998). Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States). Cancer Causes Control 9 (6): 553-557.

Kolonel, L. N., Hankin, J. H., Whittemore, A. S., Wu, A. H., Gallagher, R. P., Wilkens, L. R., John, E. M., Howe, G. R., Dreon, D. M., West, D. W., and Paffenbarger, R. S., Jr. (2000). Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol. Biomarkers Prev. 9 (8): 795-804.

Kurahashi, N., Iwasaki, M., Sasazuki, S., Otani, T., Inoue, M., and Tsugane, S. (2007). Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol. Biomarkers Prev. 16 (3): 538-545.

Lee, M. M., Gomez, S. L., Chang, J. S., Wey, M., Wang, R. T., and Hsing, A. W. (2003). Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol. Biomarkers Prev. 12 (7): 665-668.

Lee, M. M., Wang, R. T., Hsing, A. W., Gu, F. L., Wang, T., and Spitz, M. (1998). Case-control study of diet and prostate cancer in China. Cancer Causes Control 9 (6): 545-552.

Nagata, C. (2000). Ecological study of the association between soy product intake and mortality from cancer and heart disease in Japan. Int. J. Epidemiol. 29 (5): 832-836.

Nomura, A. M., Hankin, J. H., Lee, J., and Stemmermann, G. N. (2004). Cohort study of tofu intake and prostate cancer: no apparent association. Cancer Epidemiol. Biomarkers Prev. 13 (12): 2277-2279.

Ozasa, K., Nakao, M., Watanabe, Y., Hayashi, K., Miki, T., Mikami, K., Mori, M., Sakauchi, F., Washio, M., Ito, Y., Suzuki, K., Wakai, K., and Tamakoshi, A. (2004). Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men. Cancer Sci. 95 (1): 65-71.

Severson, R. K., Nomura, A. M., Grove, J. S., and Stemmermann, G. N. (1989). A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res. 49 (7): 1857-1860.

Sonoda, T., Nagata, Y., Mori, M., Miyanaga, N., Takashima, N., Okumura, K., Goto, K., Naito, S., Fujimoto, K., Hirao, Y., Takahashi, A., Tsukamoto, T., Fujioka, T., and Akaza, H. (2004). A case-control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet. Cancer Sci. 95 (3): 238-242.

Strom, S. S., Yamamura, Y., Duphorne, C. M., Spitz, M. R., Babaian, R. J., Pillow, P. C., and Hursting, S. D. (1999). Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nutr. Cancer 33 (1): 20-25.

Sung, J. F., Lin, R. S., Pu, Y. S., Chen, Y. C., Chang, H. C., and Lai, M. K. (1999). Risk factors for prostate carcinoma in Taiwan: a case-control study in a Chinese population. Cancer 86 (3): 484-491.

Villeneuve, P. J., Johnson, K. C., Kreiger, N., and Mao, Y. (1999). Risk factors for prostate cancer: results from the Canadian National Enhanced Cancer Surveillance System. The Canadian Cancer Registries Epidemiology Research Group. Cancer Causes Control 10 (5): 355-367.



Soja und Herz-Kreislauf-Erkrankungen

Vgl. http://www.isoflavon-forschung.de/de/clinical-effects/cardiovascular-effects/118-cardiovascular-studies.html (dort drei Studien)



Soja und geistige Leistungsfähigkeit

Vgl. http://www.isoflavon-forschung.de/de/clinical-effects/cognitive-performance/119-cognitive-functions.html

Zitat:
Basaria, S., Wisniewski, A., Dupree, K., Bruno, T., Song, M. Y., Yao, F., Ojumu, A., John, M., und Dobs, A. S. (2009). Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women. J. Endocrinol. Invest 32 (2): 150-155.

Carswell, H. V., Macrae, I. M., Gallagher, L., Harrop, E., und Horsburgh, K. J. (2004). Neuroprotection by a selective estrogen receptor beta agonist in a mouse model of global ischemia. Am J. Physiol Heart Circ. Physiol 287 (4): H1501-H1504.

Casini, M. L., Marelli, G., Papaleo, E., Ferrari, A., D'Ambrosio, F., und Unfer, V. (2006). Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: a randomized, double-blind, crossover, placebo-controlled study. Fertil. Steril. 85 (4): 972-978.

Duffy, R., Wiseman, H., und File, S. E. (2003). Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacol. Biochem. Behav. 75 (3): 721-729.

File, S. E., Jarrett, N., Fluck, E., Duffy, R., Casey, K., und Wiseman, H. (2001). Eating soya improves human memory. Psychopharmacology (Berl) 157 (4): 430-436.

Fournier, L. R., Ryan Borchers, T. A., Robison, L. M., Wiediger, M., Park, J. S., Chew, B. P., McGuire, M. K., Sclar, D. A., Skaer, T. L., und Beerman, K. A. (2007). The effects of soy milk and isoflavone supplements on cognitive performance in healthy, postmenopausal women. J. Nutr. Health Aging 11 (2): 155-164.

Fugger, H. N., Cunningham, S. G., Rissman, E. F., und Foster, T. C. (1998). Sex differences in the activational effect of ERalpha on spatial learning. Horm. Behav. 34 (2): 163-170.

Fugger, H. N., Foster, T. C., Gustafsson, J., und Rissman, E. F. (2000). Novel effects of estradiol and estrogen receptor alpha and beta on cognitive function. Brain Res. 883 (2): 258-264.

Gleason, C. E., Carlsson, C. M., Barnet, J. H., Meade, S. A., Setchell, K. D., Atwood, C. S., Johnson, S. C., Ries, M. L., und Asthana, S. (2009). A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women. Age Ageing 38 (1): 86-93.

Ho, S. C., Chan, A. S., Ho, Y. P., So, E. K., Sham, A., Zee, B., und Woo, J. L. (2007). Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: a double-blind, randomized, controlled trial. Menopause 14 (3 Pt 1): 489-499.

Hogervorst, E., Sadjimim, T., Yesufu, A., Kreager, P., und Rahardjo, T. B. (2008). High Tofu Intake Is Associated with Worse Memory in Elderly Indonesian Men and Women. Dement. Geriatr. Cogn Disord. 26 (1): 50-57.

Islam, F., Sparkes, C., Roodenrys, S., und Astheimer, L. (2008). Short-term changes in endogenous estrogen levels and consumption of soy isoflavones affect working and verbal memory in young adult females. Nutr. Neurosci. 11 (6): 251-262.

Kreijkamp-Kaspers, S., Kok, L., Grobbee, D. E., de Haan, E. H., Aleman, A., Lampe, J. W., und van der Schouw, Y. T. (2004). Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 292 (1): 65-74.

Kritz-Silverstein, D., Von Muhlen, D., Barrett-Connor, E., und Bressel, M. A. (2003). Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause 10 (3): 196-202.

Lee, Y. B., Lee, H. J., und Sohn, H. S. (2005). Soy isoflavones and cognitive function. J. Nutr. Biochem. 16 (11): 641-649.

Lee, Y. B., Lee, H. J., Won, M. H., Hwang, I. K., Kang, T. C., Lee, J. Y., Nam, S. Y., Kim, K. S., Kim, E., Cheon, S. H., und Sohn, H. S. (2004). Soy isoflavones improve spatial delayed matching-to-place performance and reduce cholinergic neuron loss in elderly male rats. J. Nutr. 134 (7): 1827-1831.

Linford, N. J. und Dorsa, D. M. (2002). 17beta-Estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin. Steroids 67 (13-14): 1029-1040.

Lund, T. D., West, T. W., Tian, L. Y., Bu, L. H., Simmons, D. L., Setchell, K. D., Adlercreutz, H., und Lephart, E. D. (2001). Visual spatial memory is enhanced in female rats (but inhibited in males) by dietary soy phytoestrogens. BMC Neurosci. 2: 20

Nilsen, J., Mor, G., und Naftolin, F. (2000). Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system. J. Neurobiol. 43 (1): 64-78.

Rissman, E. F., Heck, A. L., Leonard, J. E., Shupnik, M. A., und Gustafsson, J. A. (2002). Disruption of estrogen receptor beta gene impairs spatial learning in female mice. Proc Natl. Acad. Sci. U. S A 99 (6): 3996-4001.

Sampei, K., Goto, S., Alkayed, N. J., Crain, B. J., Korach, K. S., Traystman, R. J., Demas, G. E., Nelson, R. J., und Hurn, P. D. (2000). Stroke in estrogen receptor-alpha-deficient mice. Stroke 31 (3): 738-743.

Thorp, A. A., Sinn, N., Buckley, J. D., Coates, A. M., und Howe, P. R. (2009). Soya isoflavone supplementation enhances spatial working memory in men. Br. J. Nutr. 1-7.

White, L. R., Petrovitch, H., Ross, G. W., Masaki, K., Hardman, J., Nelson, J., Davis, D., und Markesbery, W. (2000). Brain aging and midlife tofu consumption. J. Am Coll. Nutr. 19 (2): 242-255.

Zhao, L., Mao, Z., und Brinton, R. D. (2009). A select combination of clinically relevant phytoestrogens enhances estrogen receptor beta-binding selectivity and neuroprotective activities in vitro and in vivo. Endocrinology 150 (2): 770-783



Soja und entzündungshemmende Effekte

Vgl. http://www.isoflavon-forschung.de/de/clinical-effects/inflammatory-disorders/120-other-effects.html (dort vier Studien)


Soja und Wechseljahresbeschwerden

Erläuterungen und die zusammengefaßten Ergebnisse der einzelnen Studien als pdf unter: http://www.isoflavon-forschung.de/de/clinical-effects/menopausal-disorders/116-menopause-clinical-studies.html

Zitat:
Anon. (2007). Positionspapier der Internationalen und Österreichischen Menopausegesellschaft. Sekretariat Österreichische Menopausegesellschaft.

Albert, A., Altabre, C., Baro, F., Buendia, E., Cabero, A., Cancelo, M. J., Castelo-Branco, C., Chantre, P., Duran, M., Haya, J., Imbert, P., Julia, D., Lanchares, J. L., Llaneza, P., Manubens, M., Minano, A., Quereda, F., Ribes, C., und Vazquez, F. (2002). Efficacy and safety of a phytoestrogen preparation derived from Glycine max (L.) Merr in climacteric symptomatology: a multicentric, open, prospective and non-randomized trial. Phytomedicine 9 (2): 85-92.

Albertazzi, P., Pansini, F., Bonaccorsi, G., Zanotti, L., Forini, E., und De Aloysio, D. (1998). The effect of dietary soy supplementation on hot flushes. Obstet. Gynecol. 91 (1): 6-11.

Albertazzi, P., Steel, S. A., und Bottazzi, M. (2005). Effect of pure genistein on bone markers and hot flushes. Climacteric. 8 (4): 371-379.

Brzezinski, A., Adlercreutz, H., Shaoul, R., Rösler, A., Shmueli, A., Tanos, V., und Schenker, J. G. (1997). Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause 4 (2): 89-94.

Burke, G. L., Legault, C., Anthony, M., Bland, D. R., Morgan, T. M., Naughton, M. J., Leggett, K., Washburn, S. A., und Vitolins, M. Z. (2003). Soy protein and isoflavone effects on vasomotor symptoms in peri- and postmenopausal women: the Soy Estrogen Alternative Study. Menopause 10 (2): 147-153.

Campagnoli, C., Abba, C., Ambroggio, S., Peris, C., Perona, M., und Sanseverino, P. (2005). Polyunsaturated fatty acids (PUFAs) might reduce hot flushes: an indication from two controlled trials on soy isoflavones alone and with a PUFA supplement. Maturitas 51 (2): 127-134.

Cassidy, A., Brown, J. E., Hawdon, A., Faughnan, M. S., King, L. J., Millward, J., Zimmer-Nechemias, L., Wolfe, B., und Setchell, K. D. (2006). Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. J. Nutr. 136 (1): 45-51.

Cheng, G., Wilczek, B., Warner, M., Gustafsson, J. A., und Landgren, B. M. (2007). Isoflavone treatment for acute menopausal symptoms. Menopause 14 (3 Pt 1): 468-473.

Colacurci, N., Zarcone, R., Borrelli, A., De Franciscis, P., Fortunato, N., Cirillo, M., und Fornaro, F. (2004). Effects of soy isoflavones on menopausal neurovegetative symptoms. Minerva Ginecol. 56 (5): 407-412.

Crisafulli, A., Marini, H., Bitto, A., Altavilla, D., Squadrito, G., Romeo, A., Adamo, E. B., Marini, R., D'Anna, R., Corrado, F., Bartolone, S., Frisina, N., und Squadrito, F. (2004). Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo-controlled study. Menopause 11 (4): 400-404.

D'Anna, R., Cannata, M. L., Atteritano, M., Cancellieri, F., Corrado, F., Baviera, G., Triolo, O., Antico, F., Gaudio, A., Frisina, N., Bitto, A., Polito, F., Minutoli, L., Altavilla, D., Marini, H., und Squadrito, F. (2007). Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study. Menopause 14 (4): 648-655.

Dalais, F. S., Rice, G. E., Wahlqvist, M. L., Grehan, M., Murkies, A. L., Medley, G., Ayton, R., und Strauss, B. J. (1998). Effects of dietary phytoestrogens in postmenopausal women. Climacteric. 1 (2): 124-129.

Drapier Faure, E., Chantre, P., und Mares, P. (2002). Effects of a standardized soy extract on hot flushes: a multicenter, double-blind, randomized, placebo-controlled study. Menopause 9 (5): 329-334.

FDA (2003). Guidance for Industry. Estrogen and estrogen/progestin drug prudcuts to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms - recommendations for clinical evaluation. Online at http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM135338.pdf

Gocan, A., Dellar, M., Dellar, G., Rohr, U., Reithmayr, F., Lipovac, M., und Imhof, M. (2007). Placebo-controlled clinical study of soy-isoflavone exhibits significant relief for menopausal symptoms. 7th Congress of the Turkish-German Gynaecological Association (TGGA), Antalya. May 16-20

Han, K. K., Soares, J. M., Jr., Haidar, M. A., de Lima, G. R., und Baracat, E. C. (2002). Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet. Gynecol. 99 (3): 389-394.

Howes, L. G., Howes, J. B., und Knight, D. C. (2006). Isoflavone therapy for menopausal flushes: a systematic review and meta-analysis. Maturitas 55 (3): 203-211.

Ikeda, Y., Iki, M., Morita, A., Kajita, E., Kagamimori, S., Kagawa, Y., und Yoneshima, H. (2006). Intake of fermented soybeans, natto, is associated with reduced bone loss in postmenopausal women: Japanese Population-Based Osteoporosis (JPOS) Study. J. Nutr. 136 (5): 1323-1328.

Imhof, M., Gocan, A., Imhof, M., und Schmidt, M. (2008). Improvement of menopausal symptoms by soy isoflavones: A randomized, double-blind study. Planta Med 74 (9): 928.

Kaari, C., Haidar, M. A., Junior, J. M., Nunes, M. G., Quadros, L. G., Kemp, C., Stavale, J. N., und Baracat, E. C. (2006). Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas 53 (1): 49-58.

Khaodhiar, L., Ricciotti, H. A., Li, L., Pan, W., Schickel, M., Zhou, J., und Blackburn, G. L. (2008). Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women. Menopause 15 (1): 125-132.

Kim, H. W., Kwon, M. K., Kim, N. S., und Reame, N. E. (2006). Intake of dietary soy isoflavones in relation to perimenstrual symptoms of Korean women living in the USA. Nurs. Health Sci. 8 (2): 108-113.

Knight, D. C., Howes, J. B., Eden, J. A., und Howes, L. G. (2001). Effects on menopausal symptoms and acceptability of isoflavone-containing soy powder dietary supplementation. Climacteric. 4 (1): 13-18.

Kotsopoulos, D., Dalais, F. S., Liang, Y. L., McGrath, B. P., und Teede, H. J. (2000). The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric. 3 (3): 161-167.Kurzer, M. S. (2008). Soy Consumption for Reduction of Menopausal Symptoms. Inflammopharmacology. 16: 1-3.

Kurzer, M.S. (2009). Soy isoflavones reduce postmenopausal hot flush frequency and severity: Results of a systematic review and meta-analysis of randomized controlled trials. Symposium on Evaluating the Efficacy and Safety of Isoflavones for Postmenopausal Women, 13-14 May. Milan (Italy): Council for Responsible Nutrition.

McCarty, M. F. (2006). Isoflavones made simple - Genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits. Med. Hypotheses 66 (6): 1093-1114.

Messina, M. und Hughes, C. (2003). Efficacy of soyfoods and soybean isoflavone supplements for alleviating menopausal symptoms is positively related to initial hot flush frequency. J. Med. Food 6 (1): 1-11.

Messina, M., Kucuk, O., und Lampe, J. W. (2006a). An overview of the health effects of isoflavones with an emphasis on prostate cancer risk and prostate-specific antigen levels. J. AOAC Int. 89 (4): 1121-1134.

Messina, M., Nagata, C., und Wu, A. H. (2006b). Estimated Asian adult soy protein and isoflavone intakes. Nutr. Cancer 55 (1): 1-12.

Murkies, A. L., Lombard, C., Strauss, B. J., Wilcox, G., Burger, H. G., und Morton, M. S. (1995). Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas 21 (3): 189-195.

Nagata, C., Shimizu, H., Takami, R., Hayashi, M., Takeda, N., und Yasuda, K. (1999). Hot flushes and other menopausal symptoms in relation to soy product intake in Japanese women. Climacteric. 2 (1): 6-12.

Nagata, C., Takatsuka, N., Kawakami, N., und Shimizu, H. (2001). Soy product intake and hot flashes in Japanese women: results from a community-based prospective study. Am J. Epidemiol. 153 (8): 790-793.

Nahas, E. A. P., Nahas-Neto, J., Orsatti, F. L., Carvalho, E. P., Oliveira, M. L., und Dias, R. (2007). Efficacy and safety of a soy isoflavone extract in postmenopausal women: A randomized, double-blind, and placebo-controlled study. Maturitas 58 (3): 249-258.

Nelson, H. D., Vesco, K. K., Haney, E., Fu, R., Nedrow, A., Miller, J., Nicolaidis, C., Walker, M., und Humphrey, L. (2006). Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 295 (17): 2057-2071.

Nielsen, I. L. und Williamson, G. (2007). Review of the factors affecting bioavailability of soy isoflavones in humans. Nutr. Cancer 57 (1): 1-10.

Penotti, M., Fabio, E., Modena, A. B., Rinaldi, M., Omodei, U., und Vigano, P. (2003). Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries. Fertil. Steril. 79 (5): 1112-1117.

Petri Nahas, E. A., Nahas Neto, J., De Luca, L., Traiman, P., Pontes, A., und Dalben, I. (2004). Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy. Maturitas 48 (4): 372-380.

Qin, L. Q., Xu, J. Y., Wang, P. Y., und Hoshi, K. (2006). Soyfood intake in the prevention of breast cancer risk in women: a meta-analysis of observational epidemiological studies. J. Nutr. Sci. Vitaminol. (Tokyo) 52 (6): 428-436.

Ricciotti, H. A., Khaodhiar, L., und Blackburn, G. L. (2005). Daidzein-rich isoflavone-aglycones for menopausal symptoms. Int. J. Gynaecol. Obstet. 89 (1): 65-66.

Scambia, G., Mango, D., Signorile, P. G., Anselmi Angeli, R. A., Palena, C., Gallo, D., Bombardelli, E., Morazzoni, P., Riva, A., und Mancuso, S. (2000). Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause 7 (2): 105-111.

Schindler, A. E. (2006). Wie sinnvoll ist die Kombination von Sexualsteroiden und Phytohormonen? Gyne (4): 82-84.

St Germain, A., Peterson, C. T., Robinson, J. G., und Alekel, D. L. (2001). Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause 8 (1): 17-26.

Uesugi, S., Watanabe, S., Ishiwata, N., Uehara, M., und Ouchi, K. (2004). Effects of isoflavone supplements on bone metabolic markers and climacteric symptoms in Japanese women. Biofactors 22 (1-4): 221-228.

Upmalis, D. H., Lobo, R., Bradley, L., Warren, M., Cone, F. L., und Lamia, C. A. (2000). Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study. Menopause 7 (4): 236-242.

Verhoeven, M. O., Teerlink, T., Kenemans, P., Zuijdgeest-van Leeuwen, S. D., und van der Mooren, M. J. (2007). Effects of a supplement containing isoflavones and Actaea racemosa L. on asymmetric dimethylarginine, lipids, and C-reactive protein in menopausal women. Fertil. Steril. 87 (4): 849-857.

Verhoeven, M. O., van der Mooren, M. J., van de Weijer, P. H., Verdegem, P. J., van der Burgt, L. M., und Kenemans, P. (2005). Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomized, placebo-controlled, double-blind study. Menopause 12 (4): 412-420.

Washburn, S., Burke, G. L., Morgan, T., und Anthony, M. (1999). Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 6 (1): 7-13.

Welty, F. K., Lee, K. S., Lew, N. S., Nasca, M., und Zhou, J. R. (2007). The association between soy nut consumption and decreased menopausal symptoms. J. Womens Health (Larchmt. ) 16 (3): 361-369.

Williamson-Hughes, P. S., Flickinger, B. D., Messina, M. J., und Empie, M. W. (2006). Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: a critical review of published studies. Menopause 13 (5): 831-839.



Soja und Krebsschutzmechanismen allgemein

Vgl. http://www.isoflavon-forschung.de/de/cancer/protective-mechanisms.html und Unterseiten

Zitat:
Farina, H. G., Pomies, M., Alonso, D. F., und Gomez, D. E. (2006). Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol. Rep. 16 (4): 885-891.

Owen, J. L., Torroella-Kouri, M., und Iragavarapu-Charyulu, V. (2008). Molecular events involved in the increased expression of matrix metalloproteinase-9 by T lymphocytes of mammary tumor-bearing mice. Int. J. Mol. Med 21 (1): 125-134.

Anandanadesan, R., Gong, Q., Chipitsyna, G., Witkiewicz, A., Yeo, C. J., und Arafat, H. A. (2007). Angiotensin II Induces Vascular Endothelial Growth Factor in Pancreatic Cancer Cells Through an Angiotensin II Type 1 Receptor and ERK1/2 Signaling. J. Gastrointest. Surg. 12: 57-66.

Guo, Y., Wang, S., Hoot, D. R., und Clinton, S. K. (2007). Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones. J. Nutr. Biochem. 18 (6): 408-417.

Piao, M., Mori, D., Satoh, T., Sugita, Y., und Tokunaga, O. (2006). Inhibition of endothelial cell proliferation, in vitro angiogenesis, and the down-regulation of cell adhesion-related genes by genistein. Combined with a cDNA microarray analysis. Endothelium 13 (4): 249-266.

Schindler, R. und Mentlein, R. (2006). Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells. J. Nutr. 136 (6): 1477-1482.

Alvero, A. B., Brown, D., Montagna, M., Matthews, M., und Mor, G. (2007). Phenoxodiol-Topotecan co-administration exhibit significant anti-tumor activity without major adverse side effects. Cancer Biol. Ther. 6 (4): 612-617.

Choueiri, T. K., Mekhail, T., Hutson, T. E., Ganapathi, R., Kelly, G. E., und Bukowski, R. M. (2006a). Phase I trial of phenoxodiol delivered by continuous intravenous infusion in patients with solid cancer. Ann. Oncol. 17 (5): 860-865.

Choueiri, T. K., Wesolowski, R., und Mekhail, T. M. (2006b). Phenoxodiol: isoflavone analog with antineoplastic activity. Curr. Oncol. Rep. 8 (2): 104-107.

Constantinou, A. I. und Husband, A. (2002). Phenoxodiol (2H-1-benzopyran-7-0,1,3-(4-hydroxyphenyl)), a novel isoflavone derivative, inhibits DNA topoisomerase II by stabilizing the cleavable complex. Anticancer Res. 22 (5): 2581-2585.

de Souza, P. L., Liauw, W., Links, M., Pirabhahar, S., Kelly, G., und Howes, L. G. (2006). Phase I and pharmacokinetic study of weekly NV06 (Phenoxodiol), a novel isoflav-3-ene, in patients with advanced cancer. Cancer Chemother. Pharmacol. 58 (4): 427-433.

Farina, H. G., Pomies, M., Alonso, D. F., und Gomez, D. E. (2006). Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol. Rep. 16 (4): 885-891.

Gamble, J. R., Xia, P., Hahn, C. N., Drew, J. J., Drogemuller, C. J., Brown, D., und Vadas, M. A. (2006). Phenoxodiol, an experimental anticancer drug, shows potent antiangiogenic properties in addition to its antitumour effects. Int. J. Cancer 118 (10): 2412-2420.

Kiriakidis, S., Hogemeier, O., Starcke, S., Dombrowski, F., Hahne, J. C., Pepper, M., Jha, H. C., und Wernert, N. (2005). Novel tempeh (fermented soyabean) isoflavones inhibit in vivo angiogenesis in the chicken chorioallantoic membrane assay. Br. J. Nutr. 93 (3): 317-323.

Klein, R., Brown, D., und Turnley, A. M. (2007). Phenoxodiol protects against Cisplatin induced neurite toxicity in a PC-12 cell model. BMC Neurosci. 8: 61

Kluger, H. M., McCarthy, M. M., Alvero, A. B., Sznol, M., Ariyan, S., Camp, R. L., Rimm, D. L., und Mor, G. (2007). The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization. J. Transl. Med 5: 6-21.

McDonnell, C. O., Holden, G., Sheridan, M. E., Foley, D., Moriarty, M., Walsh, T. N., und Bouchier-Hayes, D. J. (2004). Improvement in efficacy of chemoradiotherapy by addition of an antiangiogenic agent in a murine tumor model. J. Surg. Res. 116 (1): 19-23.

Mor, G., Fu, H. H., und Alvero, A. B. (2006). Phenoxodiol, a novel approach for the treatment of ovarian cancer. Curr. Opin. Investig. Drugs 7 (6): 542-548.

Morre, D. J., Chueh, P. J., Yagiz, K., Balicki, A., Kim, C., und Morre, D. M. (2007). ECTO-NOX target for the anticancer isoflavene phenoxodiol. Oncol. Res. 16 (7): 299-312.

Oh, H. Y., Kwon, S. M., Kim, S. I., Jae, Y. W., und Hong, S. J. (2005). Antiangiogenic effect of ZD1839 against murine renal cell carcinoma (RENCA) in an orthotopic mouse model. Urol. Int. 75 (2): 159-166.

Pietras, R. J. und Weinberg, O. K. (2005). Antiangiogenic Steroids in Human Cancer Therapy. Evid. Based Complement Alternat. Med 2 (1): 49-57.

Ravindranath, M. H., Muthugounder, S., Presser, N., und Viswanathan, S. (2004). Anticancer therapeutic potential of soy isoflavone, genistein. Adv. Exp. Med Biol. 546: 121-165.

Gamble, J. R., Xia, P., Hahn, C. N., Drew, J. J., Drogemuller, C. J., Brown, D., und Vadas, M. A. (2006). Phenoxodiol, an experimental anticancer drug, shows potent antiangiogenic properties in addition to its antitumour effects. Int. J. Cancer 118 (10): 2412-2420.

Gu, Y., Zhu, C. F., Iwamoto, H., und Chen, J. S. (2005). Genistein inhibits invasive potential of human hepatocellular carcinoma by altering cell cycle, apoptosis, and angiogenesis. World J. Gastroenterol. 11 (41): 6512-6517.

Handayani, R., Rice, L., Cui, Y., Medrano, T. A., Samedi, V. G., Baker, H. V., Szabo, N. J., und Shiverick, K. T. (2006). Soy isoflavones alter expression of genes associated with cancer progression, including interleukin-8, in androgen-independent PC-3 human prostate cancer cells. J. Nutr. 136 (1): 75-82.

Ho, S. M. (2004). Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates. J. Cell Biochem. 91 (3): 491-503.

Singh, A. V., Franke, A. A., Blackburn, G. L., und Zhou, J. R. (2006). Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis. Cancer Res. 66 (3): 1851-1858.

 Beitrag beantworten  •  Gesamtbeiträge   neueres Thema  •  früheres Thema 

 Themen Name  Datum
 Die (wirkliche) Wahrheit über Soja   neu 
 martin 10.10.09 10:13 
 Studien   neu 
 martin 10.10.09 10:14 
 Re: Die (wirkliche) Wahrheit über Soja   neu 
 Paddelz 10.10.09 17:53 
 Re: Die (wirkliche) Wahrheit über Soja   neu 
 martin 11.10.09 09:06 
 Ursachen der Sojadenunziation   neu 
 martin 25.10.09 15:35 
 Re: Ursachen der Sojadenunziation   neu 
 Angi 07.12.16 12:27 
 Re: Ursachen der Sojadenunziation   neu 
 Achim Stößer 07.12.16 20:55 
 Re: Die (wirkliche) Wahrheit über Soja   neu 
 K.D. 04.11.09 21:14 
 Re: Die (wirkliche) Wahrheit über Soja   neu 
 Achim Stößer 04.11.09 22:25 
 Atmen ist unnatürlich   neu 
 martin 05.11.09 08:36 
 Re: Atmen ist unnatürlich   neu 
 K.D. 05.11.09 15:00 
 Re: Atmen ist unnatürlich   neu 
 Tobi 05.11.09 15:14 
 Re: Atmen ist unnatürlich   neu 
 martin 05.11.09 17:12 
 Re: Atmen ist unnatürlich   neu 
 K.D. 05.11.09 23:30 
 Dichtung und Wahrheit   neu 
 martin 06.11.09 16:49 
 Re: Dichtung und Wahrheit   neu 
 K.D. 06.11.09 19:05 
 Re: Dichtung und Wahrheit   neu 
 martin 07.11.09 09:29 
 Re: Dichtung und Wahrheit   neu 
 human 08.01.10 15:50 
 Cadmium   neu 
 martin 08.01.10 17:42 
 Re: Cadmium   neu 
 human 10.01.10 14:28 
 Re: Cadmium   neu 
 Achim Stößer 10.01.10 15:16 
 Re: Cadmium   neu 
 human 11.01.10 11:52 
 Aminosäuren   neu 
 RedNeo 11.01.10 13:16 
 Re: Cadmium   neu 
 Marco 11.01.10 16:29 
 Re: Cadmium   neu 
 martin 11.01.10 18:05 
 Re: Cadmiumanreicherung   neu 
 Trolli 11.01.10 23:45 
 Re: Cadmium   neu 
 martin 10.01.10 16:21 
 Re: Cadmium   neu 
 human 11.01.10 12:18 
 Re: Cadmium   neu 
 martin 11.01.10 17:53 
 Re: Dichtung und Wahrheit   neu 
 Steffibeffi 14.09.10 22:11 
 Sojabohnen   neu 
 martin 14.09.10 22:20 
 Re: Sojabohnen   neu 
 Achim Stößer 17.09.10 22:28 
 Salat mit einem Kilo Sojabohnen?   neu 
 Achim Stößer 17.09.10 22:33 
 Re: Die (wirkliche) Wahrheit über Soja   neu 
 Maria 23.10.10 20:27 
 Re: Die (wirkliche) Wahrheit über Soja   neu 
 Marco 24.10.10 01:46 
 Metastudie: Auswirkung von Soja auf Testosteron   neu 
 martin 24.10.10 17:49 
 Mir geht es besser Ohne   neu 
 NikiM165 29.07.11 07:30 
 Gynäkomastie von Sojamilch   neu 
 E 15.08.12 09:40 
 Re: Gynäkomastie von Sojamilch   neu 
 martin 16.08.12 20:57 
 Re: Gynäkomastie von Sojamilch   neu 
 E 17.08.12 10:18 
 Meinungen usw.   neu 
 martin 18.08.12 21:19 
 Re: Gynäkomastie von Sojamilch   neu 
 E 20.08.12 15:45 
 Re: Gynäkomastie von Sojamilch   neu 
 Gast 20.08.12 17:52 
 Re: Gynäkomastie von Sojamilch   neu 
 Gästin 08.12.16 13:48 
 Re: Gynäkomastie von Sojamilch   neu 
 Achim Stößer 08.12.16 19:06 
 Re: Gynäkomastie von Sojamilch   neu 
 Ava von Auswärts 20.08.12 14:01 
 Re: Mir geht es besser Ohne   neu 
 Ava von Auswärts 20.08.12 13:36 


 Forenübersicht  •  neues Thema  •  nach oben  •  zum Thema  •  Suche  •  Anmelden  •  RSS 
 Beitrag beantworten
 Name:
 Email:
 Spamschutz: Dieser Code muss kopiert werden 
 Titel:
  [b]fett[/b] | [i]kursiv[/i] | [u]unterstrichen[/u] | [quote]Zitat[/quote]
  [url]http://[/url] | [url=http://]Linktext[/url] | [img]Bild[/img]
  Richtlinien sowie Forenbeschreibung und FAQ gelesen?
  Suchfunktion benutzt?
   
Vegan
Tierrechte